These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 25085901)
21. Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. Yin L; Kosugi M; Kufe D Blood; 2012 Jan; 119(3):810-6. PubMed ID: 22117045 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas. Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3. Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
25. miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer. Ge P; Cao L; Chen X; Jing R; Yue W BMC Cancer; 2019 Dec; 19(1):1203. PubMed ID: 31823748 [TBL] [Abstract][Full Text] [Related]
26. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity. Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318 [TBL] [Abstract][Full Text] [Related]
27. Acquired activation of the Akt/cyclooxygenase-2/Mcl-1 pathway renders lung cancer cells resistant to apoptosis. Chen W; Bai L; Wang X; Xu S; Belinsky SA; Lin Y Mol Pharmacol; 2010 Mar; 77(3):416-23. PubMed ID: 19933775 [TBL] [Abstract][Full Text] [Related]
28. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. Yin L; Li Y; Ren J; Kuwahara H; Kufe D J Biol Chem; 2003 Sep; 278(37):35458-64. PubMed ID: 12826677 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. Bar-Natan M; Stroopinsky D; Luptakova K; Coll MD; Apel A; Rajabi H; Pyzer AR; Palmer K; Reagan MR; Nahas MR; Karp Leaf R; Jain S; Arnason J; Ghobrial IM; Anderson KC; Kufe D; Rosenblatt J; Avigan D Br J Haematol; 2017 Mar; 176(6):929-938. PubMed ID: 28107546 [TBL] [Abstract][Full Text] [Related]
30. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1. Wang X; Zhou X; Zeng F; Wu X; Li H Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736 [TBL] [Abstract][Full Text] [Related]
31. MUC1 stimulates EGFR expression and function in endometrial cancer. Engel BJ; Bowser JL; Broaddus RR; Carson DD Oncotarget; 2016 May; 7(22):32796-809. PubMed ID: 27092881 [TBL] [Abstract][Full Text] [Related]
32. miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death. Jin C; Rajabi H; Kufe D Int J Oncol; 2010 Jul; 37(1):61-9. PubMed ID: 20514397 [TBL] [Abstract][Full Text] [Related]
33. MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells. Rajabi H; Ahmad R; Jin C; Joshi MD; Guha M; Alam M; Kharbanda S; Kufe D Prostate; 2012 Nov; 72(15):1659-68. PubMed ID: 22473899 [TBL] [Abstract][Full Text] [Related]
35. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
36. Nrf2/p62 signaling in apoptosis resistance and its role in cadmium-induced carcinogenesis. Son YO; Pratheeshkumar P; Roy RV; Hitron JA; Wang L; Zhang Z; Shi X J Biol Chem; 2014 Oct; 289(41):28660-75. PubMed ID: 25157103 [TBL] [Abstract][Full Text] [Related]
37. MUC1-C is a target in lenalidomide resistant multiple myeloma. Yin L; Tagde A; Gali R; Tai YT; Hideshima T; Anderson K; Avigan D; Kufe D Br J Haematol; 2017 Sep; 178(6):914-926. PubMed ID: 28643330 [TBL] [Abstract][Full Text] [Related]
38. Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition. Wang Q; Shi S; He W; Padilla MT; Zhang L; Wang X; Zhang B; Lin Y Oncotarget; 2014 Mar; 5(5):1304-14. PubMed ID: 24675421 [TBL] [Abstract][Full Text] [Related]
39. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells. Wang TH; Chen CC; Huang KY; Shih YM; Chen CY Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652 [TBL] [Abstract][Full Text] [Related]
40. MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC. Alam M; Ahmad R; Rajabi H; Kufe D Mol Cancer Res; 2015 Mar; 13(3):449-60. PubMed ID: 25368430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]